R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma

Clinical trial NCT07764601 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07764601
Sponsor: WEI XU
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Primary Central Nervous System Lymphoma Diffuse Large B-Cell Lymphoma

Start date: 2026-08-01
Primary completion: 2028-08-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.